Latest filing published 24 Jul 2019 for Mereo BioPharma Group plc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -78.1%Entry US$5.70 · Close at T+365 US$1.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Deepa Pakianathan: trading record in brief
Deepa Pakianathan discloses dealings in Mereo BioPharma Group plc to SEC (Form 4). We count 3 filings; the first trade dates from 23 April 2019 and the latest from 24 July 2019.
No open-market sale appears; the market trades are 1 purchase worth €378. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants.
On 24 July 2019 came the latest disclosure, a share grant in Mereo BioPharma Group plc. The clock since the last published purchase (26 April 2019) now reads 2,754 days. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Deepa Pakianathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,500 sharesOutside of a trading venueFCA-NSM:LSE20190724100812_14161287_20200326185123408_10441-11
- 5,500 sharesOutside of a trading venueFCA-NSM:LSE20190521150839_14082298_20200326185142080_11482-11
- 256,734 shares@ £0.0013100.0% of flowOutside Trading Venue.FCA-NSM:LSE20190426150128_14054104_20200326185041374_3148Canonical exit: 22 Jul 2019 (T+90)
3 of 3 declarations
